Health
Diabetes vaccine gives promising results in a genetic subgroup – EurekAlert
A clinical study led by Linköping University, Sweden, and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type…
IMAGE: Johnny Ludvigsson, senior professor at Linköping University.
view more
Credit: Anna Nilsen/Linköping University
A clinical study led by Linköping University and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body’s own production of insulin. The results suggest that injection of a protein, GAD, into lymph nodes can be effective in a subgroup of individuals. The results have been published in Diabetes Care.
…
-
Business13 hours agoWhere to invest $10,000 in ASX ETFs this December
-
Business12 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.
-
General8 hours agoFormer truck driver’s garage memorabilia collection sold to Westonia to drive tourism
-
Noosa News14 hours agoInside the big change in homebuyer habits during the Christmas holidays